Drug intelligence / Profile preview

thimerosal

Development stage
Phase 2
Lead developer
Eli Lilly
Modality
Small Molecules
Administration
Intramuscular, Topical
01

Overview

Thimerosal is an organomercury compound used primarily as a preservative in vaccines and other biological and pharmaceutical products to prevent the growth of bacteria and fungi. Developed in 1927, it has been widely used since the 1930s. Thimerosal is approximately 50% mercury by weight and is metabolized into ethylmercury and thiosalicylate. Its mechanism of action involves inhibiting sulfhydryl-containing active sites of various enzymes by binding to sulfhydryl compounds such as glutathione, cysteine, and protein groups. Additionally, it can activate the InsP3 calcium channel on endoplasmic reticular membranes, triggering intracellular calcium release that may affect cellular functions dependent on calcium signaling. While its use has been reduced or eliminated from most vaccines in many countries due to safety concerns—despite scientific consensus supporting its safety at low doses—it remains present in some multi-dose vials of influenza vaccine and other products[1][2][3][5].

Brand names
Merthiolate
Other names
thimerosalthiomersalmerthiolate
02

Targets

GSH (Glutathione)

Beyond the preview

Go deeper on thimerosal.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on thimerosal.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call